Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

From the authors:

B. Koch, C. Schäper, H. Völzke, R. Ewert, S. Gläser
European Respiratory Journal 2009 34: 287-288; DOI: 10.1183/09031936.00048109
B. Koch
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
C. Schäper
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
H. Völzke
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
R. Ewert
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
S. Gläser
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
  • PDF
Loading

Based on results of their important studies and assumptions concerning the Study of Health in Pomerania (SHIP) database, J.A. Neder questions the relevance of our report on reference values for cardiopulmonary exercise testing (CPET) 1. The establishment of close-to-reality reference values for the clinical interpretation of CPET is indeed an important issue since a consensus has not yet been reached on the definition of normalcy. Therefore, we consider our study to be an additional contribution to present an “ideal” set of normative values for CPET. In this context, the major strength of the current study first lies in the use of data from a large population-based sample of adults. Secondly, the consideration of echocardiographical and lung functional data besides comprehensive information on past and current medical history, as well as the performance of all kinds of clinical examination methods contributes exceedingly to the establishment of a disease-free reference sample.

J.A. Neder mainly criticises the issue of voluntary participation and the aspect of too little consideration of physical activity in the current study sample on CPET. At this point, we would like to put emphasis on the fact that the SHIP study sample itself, including the participants in CPET, was randomly selected from the general population via registration offices 2. Within a democratically ruled country, eventual participation in the study is dependent on voluntary participation. Therefore, one can argue that every epidemiological survey, to some extent, is biased, as stated in the published article; a selection bias towards younger and healthier individuals was evident. However, by means of adjusting for age and applying stringent exclusion criteria towards healthy participants, this should only marginally affect the normative limits for CPET.

J.A. Neder impeaches the applicability of the present reference values in the specific sub-population of sedentary elderly subjects since the described predicted values for peak oxygen uptake (V′O2) were systematically higher than those previously described. Besides a selection bias towards younger and slimmer volunteers our data may be biased by analysing CPET results of physically more active participants aged ≥50 yrs (<2 h·week−1 versus ≥2 h·week−1; p<0.01). Within the group of participants in CPET (n = 534 versus n = 1,174) no significant difference in the levels of physical activity was found (p = 0.241). So far, we agree with J.A. Neder. However, in our view the effect of excluding participants with coexisting and as yet unknown diseases has been shown to have an even more important impact in this subpopulation. Due to results derived within the examination process, 74% of the subjects aged >50 yrs had to be excluded. This clearly shows the importance of a wide spectrum of examination methods beside patients self report to detect and consequently exclude coexisting pathologies. Neder et al. 3 tried hard to establish a disease free study sample, but alike comparable studies to some extent all cardiorespiratory disorders might not have been detected in advance. Furthermore, the majority of studies concerning reference values might be criticised for not being population based and, thus, of limited comparability to our study design. Besides less accurately assessed exclusion criteria, another major shortcoming of other previous studies seems to be the inclusion of individuals who smoke even though an impact of cigarette smoking on exercise capacity assessed by peak V′O2 and V′O2 at anaerobic threshold has been shown 4, 5.

One can easily argue that every existing study on reference values for CPET shows limitations. Nevertheless, every piece of work on this issue seems to contribute to close-to-reality normative values. It is incontrovertible that the present findings are the first considering such an amount of different medical examination methods for the establishment of a healthy study sample across a wide age range. However, everybody working on reference values for CPET should be encouraged to do so, since, and at this point we completely agree with J.A. Neder, the “ideal” set of reference values for CPET might still to be generated.

Statement of interest

None declared.

    • © ERS Journals Ltd

    References

    1. ↵
      Koch B, Schäper C, Ittermann T, et al. Reference values for cardiopulmonary exercise testing in healthy volunteers: the SHIP study. Eur Respir J 2009;33:389–397.
      OpenUrlAbstract/FREE Full Text
    2. ↵
      John U, Greiner B, Hensel E, et al. Study of Health In Pomerania (SHIP): a health examination survey in an east German region: objectives and design. Soz Praventivmed 2001;46:186–194.
      OpenUrlCrossRefPubMedWeb of Science
    3. ↵
      Neder JA, Nery LE, Castelo A, et al. Prediction of metabolic and cardiopulmonary responses to maximum cycle ergometry: a randomised study. Eur Respir J 1999;14:1304–1313.
      OpenUrlAbstract/FREE Full Text
    4. ↵
      Wasserman K, Hansen JE, Sue DY, et al. Principles of Exercise Testing and Interpretation: Including Pathophysiology and Clinical Applications. 4th Edn. Philadelphia, Lippincott Williams and Wilkins, 2004
    5. ↵
      Unverdorben M, der Bijl A, Potgieter L, et al. Effects of levels of cigarette smoke exposure on symptom-limited spiroergometry. Prev Cardiol 2007;10:83–91.
      OpenUrlCrossRefPubMed
    View Abstract
    PreviousNext
    Back to top
    View this article with LENS
    Vol 34 Issue 1 Table of Contents
    European Respiratory Journal: 34 (1)
    • Table of Contents
    • Index by author
    Email

    Thank you for your interest in spreading the word on European Respiratory Society .

    NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

    Enter multiple addresses on separate lines or separate them with commas.
    From the authors:
    (Your Name) has sent you a message from European Respiratory Society
    (Your Name) thought you would like to see the European Respiratory Society web site.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Print
    Citation Tools
    From the authors:
    B. Koch, C. Schäper, H. Völzke, R. Ewert, S. Gläser
    European Respiratory Journal Jul 2009, 34 (1) 287-288; DOI: 10.1183/09031936.00048109

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    From the authors:
    B. Koch, C. Schäper, H. Völzke, R. Ewert, S. Gläser
    European Respiratory Journal Jul 2009, 34 (1) 287-288; DOI: 10.1183/09031936.00048109
    del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
    Full Text (PDF)

    Jump To

    • Article
      • Statement of interest
      • References
    • Info & Metrics
    • PDF
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    More in this TOC Section

    • Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    • Optimised surveillance of bronchial dysplasia in risky population
    • Reply: Risk factors for disease progression in fibrotic hypersensitivity pneumonitis
    Show more Correspondence

    Related Articles

    Navigate

    • Home
    • Current issue
    • Archive

    About the ERJ

    • Journal information
    • Editorial board
    • Reviewers
    • Press
    • Permissions and reprints
    • Advertising

    The European Respiratory Society

    • Society home
    • myERS
    • Privacy policy
    • Accessibility

    ERS publications

    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS books online
    • ERS Bookshop

    Help

    • Feedback

    For authors

    • Instructions for authors
    • Publication ethics and malpractice
    • Submit a manuscript

    For readers

    • Alerts
    • Subjects
    • Podcasts
    • RSS

    Subscriptions

    • Accessing the ERS publications

    Contact us

    European Respiratory Society
    442 Glossop Road
    Sheffield S10 2PX
    United Kingdom
    Tel: +44 114 2672860
    Email: journals@ersnet.org

    ISSN

    Print ISSN:  0903-1936
    Online ISSN: 1399-3003

    Copyright © 2023 by the European Respiratory Society